维普中文期刊产品整合服务
102篇 您的检索式:作者名="BONACA"
    题名 作者 年代 出处 被引量
1Vorapaxar in the secondary prevention of atherothrombotic events显示文摘MORROW DA BRAUNWALD E BONACA MP 2012N Engl J Med2012,366,15:1
2Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial显示文摘Benjamin M Scirica Marc P Bonaca Eugene Braunwald Gaetano M De Ferrari Daniel Isaza Basil S Lewis Felix Mehrhof Piera A Merlini Sabina A Murphy Marc S Sabatine Michal Tendera Frans Van de Werf Robert Wilcox David A Morrow 2012The Lancet . 2012 (9850)2012,,9850:1
3Elevated concentration of placental growth factor (P1GF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial 显示文摘Bui All Bonaca MP Sabatine MS et 81 2012J Thromb Thrombolysis2012,34,2:1
4Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 Trial)显示文摘BONACA M P WIVIOTT S D SABATINE M S 2007Am J Cardiol2007,99,:1
5Role of ST2 in non -ST - elevation acute coronary syndrome in the MERLIN - TIMI 36Trial显示文摘KOHU P BONACA M P KAKKAR R 2012Clin Chem2012,58,1:1
6Role of ST2 in Non-ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial显示文摘KOHLI P BONACA MP KAKKAR R 0,,01:1
7Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes显示文摘Roysland R Bonaca MP Omland T 2012Heart2012,98,10:1
8Diagnostic evaluation of theMRP-8/14 for the emergency assessment of chest pain显示文摘Vora AN Bonaca MP Ruff CT 2012JThromb Thrombolysis2012,34,2:1
9Vorapaxar in the secondary prevention of atherothrombotic events 显示文摘MORROW D A BRAUNWALD E BONACA M P 2012N Engl J Med2012,366,15:1
10Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome: Observations From PROVE IT-TIMI 22显示文摘Marc P. Bonaca David A. Morrow Eugene Braunwald Christopher P. Cannon Songtao Jiang Stephanie Breher Marc S. Sabatine Tibor Kempf Lars Wallentin Kai C. Wollert 2011Arteriosclerosis Thrombosis and Vascular Biology2011,,1:1
11Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I显示文摘Bonaca M Scirica B Sabatine M 0,,19:1
12Long-term use of ticagrelor in patients with prior myocardial infarction显示文摘Bonaca MP Bhatt DL Cohen M 2015N Engl J Med2015,372,:1
13Long-term use of ticagrelor in patients with prior myocardial infarction 显示文摘Bonaca MP Bhatt DL Cohen M 2015N Engl J Med2015,372,19:1
14Elevated concentration of placental growth factor (P1GF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial显示文摘Bui AH Bonaca MP Sabatine MS 2012J Thromb Thrombolysis2012,34,:1
15Prognostic perform- ance of multiple biomarkers in patients with non-ST-segment ele- vation acute coronary syndrome:analysis from the MERLIN-TIMI 36 trial(metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myo- cardial infarction 36) 显示文摘O:Malley RG Bonaca MP Scirica BM 2014J Am Colle Cardiol2014,63,16:1
16Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial显示文摘Storey RF Angiolillo DJ Bonaca MP 2016J Am Coll Cardiol2016,67,10:1
17Glycoprotein Ⅱb-Ⅲa inhibitors in the emergency department for patients with non-ST-elevation acute coronary syndromes: principles and practices 显示文摘LEFEBVRE C W HOEKSTRA J W BONACA M 2009J Emerg Med2009,36,2:1
18Role of ST2 in non-ST- elevation acute coronary syndrome in the MERLIN-TIMI 36 trial 显示文摘Kohli P Bonaca MP Kakkar R 2012Clin Chem2012,58,:1
19Pharmacological Treatment and Current Management of Peripheral Artery Disease显示文摘Marc P. Bonaca Mark A. Creager 2015Circulation Research2015,,:1
20American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death:observations from the TRITON-TIMI 38 t显示文摘Bonaca MP Wiviott SD Braunwald E 0,,04:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费